Biologics vs. cancer
Pyxis Oncology closes $152-million Series B financing to further advance portfolio
Business & Policy News
Patent Docs: Federal Circuit narrows scope of enablement for antibody claims
Decision provides a consistent standard based on structure even though resulting scope may prove insufficient for justifying costs of commercialization
Bright Peak and Ajinomoto collaborate on immunocytokines
Bright Peak Therapeutics and Ajinomoto enter into research collaboration for novel immunocytokines
A pair of partnerships
Thermo Fisher Scientific kicks off agreements for data management and COVID-19 testing
Asher Bio bursts on the scene with $55M Series A
Asher Bio focuses on cis-targeting technology to precisely target discrete immune cell subtypes
Patent Docs: An analytic approach to patent eligibility
Trying to overcome misinterpretations of the Supreme Court's decisions on patent eligibility by district courts and the Federal Circuit
Could DMT be beneficial in stroke recovery?
Algernon Pharmaceuticals submits pre-IND meeting request for clinical research program in DMT for stroke
Roche gains GenMark
Roche will acquire the California-based diagnostics company for $1.8 billion
IntelGenx and atai partner up on psychedelics
IntelGenx announces strategic partnership with atai Life Sciences; agreement also includes equity investment by atai
Patent Docs: The importance of accounting for inventor assignments
An ounce of prevention was certainly worth the pound of its eventual cure when it comes to assigning inventions
